Hunt Anthony
Repligen Corp · Director
Hunt Anthony is listed in filings as Director at Repligen Corp. This profile follows SEC Form 4 activity through Mar 3, 2026, including sale activity and purchase activity. Recent filings connect the profile to Repligen Corp (RGEN), BioLife Solutions, Inc. (BLFS), and 908 Devices Inc. (MASS). The current snapshot covers public activity from Jun 14, 2024 to Mar 3, 2026. Reported amounts are shown as $1.2M to $466.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $896k5.7k shares | SellNov 13, 2025 | $156.22 | $137.60 | |
| $466k3k shares | SellNov 13, 2025 | $155.45 | $137.60 | |
| $448k2.9k shares | SellNov 13, 2025 | $153.14 | $137.60 | |
| $386k2.5k shares | SellNov 13, 2025 | $154.32 | $137.60 | |
| $320k2.1k shares | SellNov 13, 2025 | $152.17 | $137.60 | |
| $307k2k shares | SellNov 13, 2025 | $157.11 | $137.60 | |
| $269k1.8k shares | SellNov 13, 2025 | $151.01 | $137.60 |